T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
First Financial Corp
THFF
$970M
| $863K | ﹤0.01% |
19,679
-1,678
| -8% | -$71.4K |
|
|
HAPN
2027
Happen Inc
HAPN
$2.25B
| $862K | ﹤0.01% |
75,351
+1,359
| +2% | +$14.5K |
|
2028
Brookdale Senior Living
BKD
$3B
| $858K | ﹤0.01% |
126,346
+1,766
| +1% | +$12.6K |
|
2029
The Greenbrier Companies
GBX
$1.41B
| $857K | ﹤0.01% |
16,836
+280
| +2% | +$13.4K |
|
2030
Life Time Group Holdings
LTH
$9.79B
| $857K | ﹤0.01% |
35,069
+16,347
| +87% | +$368K |
|
2031
Protolabs
PRLB
$2.17B
| $853K | ﹤0.01% |
29,032
+979
| +3% | +$29.9K |
|
2032
Aspen Aerogels
ASPN
$510M
| $852K | ﹤0.01% |
30,763
+8,877
| +41% | +$222K |
|
2033
The RMR Group
RMR
$337M
| $852K | ﹤0.01% |
33,533
+10,018
| +43% | +$247K |
|
|
ACH
2034
Accendra Health
ACH
$84.6M
| $851K | ﹤0.01% |
54,230
+738
| +1% | +$11.2K |
|
|
AAT
2035
American Assets Trust
AAT
$1.39B
| $840K | ﹤0.01% |
31,424
-3,176
| -9% | -$80.6K |
|
|
NOVA
2036
DELISTED
Sunnova Energy
NOVA
| $840K | ﹤0.01% |
86,222
+1,231
| +1% | +$10.9K |
|
2037
OneSpan
OSPN
$609M
| $838K | ﹤0.01% |
50,232
-974
| -2% | -$14.4K |
|
2038
Delek US
DK
$4.12B
| $834K | ﹤0.01% |
44,442
+586
| +1% | +$12.4K |
|
2039
National Beverage
FIZZ
$2.9B
| $830K | ﹤0.01% |
17,677
+269
| +2% | +$12.8K |
|
2040
Adaptive Biotechnologies
ADPT
$3.89B
| $819K | ﹤0.01% |
159,823
+1,016
| +0.6% | +$4.43K |
|
2041
Pediatrix Medical
MD
$2.15B
| $819K | ﹤0.01% |
70,640
+882
| +1% | +$8.32K |
|
2042
Cannae Holdings
CNNE
$675M
| $812K | ﹤0.01% |
42,588
+613
| +1% | +$11.8K |
|
2043
Tompkins Financial
TMP
$1.44B
| $806K | ﹤0.01% |
13,947
-4,831
| -26% | -$276K |
|
2044
Worthington Steel
WS
$1.94B
| $800K | ﹤0.01% |
23,518
+1,426
| +6% | +$49K |
|
2045
Xerox
XRX
$412M
| $800K | ﹤0.01% |
77,029
+8,503
| +12% | +$91K |
|
2046
Alpha and Omega Semiconductor
AOSL
$916M
| $799K | ﹤0.01% |
21,512
-1,219
| -5% | -$46.3K |
|
2047
Dave & Buster's
PLAY
$361M
| $799K | ﹤0.01% |
23,438
+382
| +2% | +$13K |
|
2048
Shoals Technologies Group
SHLS
$1.4B
| $797K | ﹤0.01% |
141,923
-52,194
| -27% | -$312K |
|
2049
Lindsay Corp
LNN
$1.18B
| $796K | ﹤0.01% |
6,384
-107
| -2% | -$12.8K |
|
2050
Harrow
HROW
$1.48B
| $794K | ﹤0.01% |
17,648
+386
| +2% | +$13.1K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.